Inactive Instrument

22nd Century Group Share Price Nyse

Equities

Tobacco

Sales 2024 * 33.53M 2.8B Sales 2025 * 34.53M 2.88B Capitalization 10.46M 872M
Net income 2024 * -41M -3.42B Net income 2025 * -32M -2.67B EV / Sales 2024 * 0.31 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.3 x
P/E ratio 2024 *
-0.09 x
P/E ratio 2025 *
-0.11 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 88.65%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 66 28/11
Director of Finance/CFO 57 15/22/15
Chief Tech/Sci/R&D Officer - 31/17/31
Members of the board TitleAgeSince
Director/Board Member 77 12/22/12
Chief Executive Officer 66 28/11
Director/Board Member 64 19/23/19
More insiders
22nd Century Group, Inc. is an agricultural biotechnology company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands. The Company operates through a single segment named Tobacco. Its tobacco segment is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. The tobacco segment is engaged in the sale of its reduced nicotine content (RNC) cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM. It uses plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products.
Sector
Tobacco
Calendar
More about the company